Manufacture

How are reactor technologies supporting pharma companies?

How are digital technologies addressing supply chain challenges?

A synthetic system which mimics the compartmentalized nature of cells could help in the delivery of drugs.

Is the industry ready for continuous manufacturing?

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

How will the adoption of novel approaches to the development of excipients help overcome the challenges of poorly soluble APIs?

"Moving beyond Cas9 may be the secret to reducing CRISPR’s off-target effects," says Garrett Rettig.

We must never forget unmet needs when developing new medicines.

Meet two companies that are advancing pharmaceutical development and manufacture.

Can new tools lower the hurdle of high manufacturing costs for cell and gene therapies?